Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 17 (SEPTIN14P17) is a nonfunctional genomic DNA sequence in humans, classified as a pseudogene related to the protein-coding gene SEPTIN14. Pseudogenes like SEPTIN14P17 do not encode functional proteins but may be transcribed into noncoding RNA with potential regulatory effects on their cognate genes. While certain pseudogenes can exert biological effects by modulating gene expression via processes such as microRNA (miRNA) decoying or siRNA generation, there is no specific information associating SEPTIN14P17 with therapeutic targeting, molecular function, or disease relevance beyond its status as a genomic pseudogene.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 17 (SEPTIN14P17).